Literature DB >> 21452043

Apoptosis in esophagus and pancreas carcinoma cells induced by circulating microparticles is related to phosphatidyl serine and microparticle-associated caspases.

Jan Schneider1, Ansgar M Chromik, Waldemar Uhl, Andreas Mügge, Daniel Bulut.   

Abstract

Circulating microparticles (MPs) are recently discussed as "biologically active", participating in the pathology of diseases rather than being a marker of damaging processes. It was the purpose of the present study to investigate the effects of MPs, as isolated from the blood of healthy volunteers, on the induction of apoptosis and necrosis in cultured KYSE-270 esophageal and ASPC1 pancreas carcinoma cells. MPs were obtained from the blood of 20 healthy volunteers (11 women; mean age 33.3 years). Viability, apoptosis, and necrosis were determined by flow cytometry using Annexin V/propidium iodide and tetramethylrhodamine ethyl ester perchlorate (TMRE)/propidium iodide for staining. Incubation of KYSE and ASPC1 carcinoma cells with MPs (1-20.000/μl) for 48 h reduced significantly viability of the cells, and induced apoptosis, but not necrosis. This apoptotic effect was significant at a concentration of ≥1.000 MPs/μl in both cell types. Pre-treatment of MPs with either the global caspase inhibitor ZVAD-FMK or Annexin V which blocks phosphatidyl serine in the outer membrane of MPs with high affinity, almost abolished MP-induced apoptosis. A specific enzyme assay as well Western blot analysis confirmed the presence (activity, protein) of the apoptotic enzyme caspase-3 in MPs. Incubation of carcinoma cells with MPs (20.000/μl) resulted in an increase in caspase-3 protein in carcinoma cells; this increase could be prevented by pre-treatment of MPs with Annexin V. It is suggested that MPs induce concentration-dependent apoptosis in KSYE esophageal and ASPC1 pancreas carcinoma cells in vitro by transferring caspases into target cells. This process probably requires a target cell-MP interaction, and membrane-bound anionic phosphatidyl serine may be involved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21452043     DOI: 10.1007/s12032-011-9913-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

1.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

Authors:  V Combes; A C Simon; G E Grau; D Arnoux; L Camoin; F Sabatier; M Mutin; M Sanmarco; J Sampol; F Dignat-George
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

2.  Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells.

Authors:  Anna Janowska-Wieczorek; Leah A Marquez-Curtis; Marcin Wysoczynski; Mariusz Z Ratajczak
Journal:  Transfusion       Date:  2006-07       Impact factor: 3.157

3.  Isolation of human platelet membrane microparticles from plasma and serum.

Authors:  J N George; L L Thoi; L M McManus; T A Reimann
Journal:  Blood       Date:  1982-10       Impact factor: 22.113

Review 4.  Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis.

Authors:  C P Reutelingsperger; W L van Heerde
Journal:  Cell Mol Life Sci       Date:  1997-06       Impact factor: 9.261

Review 5.  Microparticles and cancer.

Authors:  Chirag Amin; Nigel Mackman; Nigel S Key
Journal:  Pathophysiol Haemost Thromb       Date:  2009-01-27

Review 6.  Microparticles and thrombotic disease.

Authors:  Pavel Davizon; José A López
Journal:  Curr Opin Hematol       Date:  2009-09       Impact factor: 3.284

7.  Endothelium-derived microparticles impair endothelial function in vitro.

Authors:  Sergey V Brodsky; Fan Zhang; Alberto Nasjletti; Michael S Goligorsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05       Impact factor: 4.733

8.  CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease.

Authors:  D Bulut; H Tüns; A Mügge
Journal:  Eur J Clin Invest       Date:  2009-01       Impact factor: 4.686

9.  Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus.

Authors:  Adrien Daigeler; Ansgar Michael Chromik; Anne Geisler; Daniel Bulut; Christoph Hilgert; Andreas Krieg; Ludger Klein-Hitpass; Marcus Lehnhardt; Waldemar Uhl; Ulrich Mittelkötter
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

10.  Platelet-derived microparticles and coagulation activation in breast cancer patients.

Authors:  Bettina Toth; Susanne Liebhardt; Kerstin Steinig; Nina Ditsch; Andreas Rank; Ingo Bauerfeind; Michael Spannagl; Klaus Friese; Armin J Reininger
Journal:  Thromb Haemost       Date:  2008-10       Impact factor: 5.249

View more
  8 in total

1.  Extracellular vesicle isolation: present and future.

Authors:  Istvan Furi; Fatemeh Momen-Heravi; Gyongyi Szabo
Journal:  Ann Transl Med       Date:  2017-06

2.  Investigating the potential of Shikonin as a novel hypertrophic scar treatment.

Authors:  Chen Fan; Yan Xie; Ying Dong; Yonghua Su; Zee Upton
Journal:  J Biomed Sci       Date:  2015-08-16       Impact factor: 8.410

Review 3.  Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.

Authors:  Jiangdong Qiu; Gang Yang; Mengyu Feng; Suli Zheng; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Mol Cancer       Date:  2018-01-05       Impact factor: 27.401

4.  TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis.

Authors:  Cristiana Barbati; Marta Vomero; Tania Colasanti; Marco Diociaiuti; Fulvia Ceccarelli; Sara Ferrigno; Annacarla Finucci; Francesca Miranda; Lucia Novelli; Carlo Perricone; Francesca Romana Spinelli; Simona Truglia; Fabrizio Conti; Guido Valesini; Cristiano Alessandri
Journal:  Arthritis Res Ther       Date:  2018-12-07       Impact factor: 5.156

Review 5.  Effects of Microvesicles on Cell Apoptosis under Hypoxia.

Authors:  Ying Guo; Jin Tan; Yuyang Miao; Zuoming Sun; Qiang Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-04-17       Impact factor: 6.543

6.  Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Laura Atehortúa; Mauricio Rojas; Gloria Vásquez; Carlos H Muñoz-Vahos; Adriana Vanegas-García; Rafael Andrés Posada-Duque; Diana Castaño
Journal:  Arthritis Res Ther       Date:  2019-01-23       Impact factor: 5.156

7.  Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury.

Authors:  Karla B Neves; Francisco J Rios; Robert Jones; Thomas Ronald Jeffry Evans; Augusto C Montezano; Rhian M Touyz
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

8.  Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.

Authors:  Jun-Qi Liu; Xi-Wen Liao; Xiang-Kun Wang; Cheng-Kun Yang; Xin Zhou; Zheng-Qian Liu; Quan-Fa Han; Tian-Hao Fu; Guang-Zhi Zhu; Chuang-Ye Han; Hao Su; Jian-Lu Huang; Guo-Tian Ruan; Ling Yan; Xin-Ping Ye; Tao Peng
Journal:  BMC Gastroenterol       Date:  2020-12-10       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.